Why Becton, Dickinson and Company (BDX) Stock Rose 5.6% on Nov 4, 2026
What happened
Becton, Dickinson (BDX) rose 5.37% to $208.81, driven by anticipation ahead of tomorrow's Q4 fiscal 2026 earnings release (November 5 before market open), per web catalyst. Wall Street consensus expects adjusted EPS of $4.06–$4.07 and revenue near $5.11 billion. Volume surged to 3.49M shares—2.21x the typical level at this point in the session—and the stock hit new 52-week highs, buoyed by positive sentiment from the prior quarter's earnings beat and recent analyst coverage upgrades.
BDX Q4 fiscal 2026 earnings release and guidance, scheduled for Thursday, November 5, 2026, before market open.
Other developments that session
BD appoints Bridget Bagnato as worldwide president of Peripheral Intervention business unit effective November 16.
Frequently asked questions
Why did Becton, Dickinson and Company (BDX) stock rise on Nov 4, 2026?
Becton, Dickinson (BDX) rose 5.37% to $208.81, driven by anticipation ahead of tomorrow's Q4 fiscal 2026 earnings release (November 5 before market open), per web catalyst. Wall Street consensus expects adjusted EPS of $4.06–$4.07 and revenue near $5.11 billion. Volume surged to 3.49M shares—2.21x the typical level at this point in the session—and the stock hit new 52-week highs, buoyed by positive sentiment from the prior quarter's earnings beat and recent analyst coverage upgrades.
How much did BDX stock rise on Nov 4, 2026?
BDX rose 5.6% during the Nov 4, 2026 trading session.